Lagatar24 Desk
New Delhi, May 26: The WHO-listed Covid-19 vaccine, COVAXIN, developed by Bharat Biotech, was approved by the German government on Thursday for travel to the nation from June 1.
“Germany has approved Covaxin COVID19 vaccine. The entrants will no longer need proof of vaccination as the Federal Cabinet relaxes restrictions,” Bharat Biotech said on Twitter.
COVAXIN was added to a growing portfolio of vaccines validated for the prevention of COVID-19 caused by SARS-CoV-2 by the World Health Organization (WHO) in November of last year.
“Very happy that GER government just decided to recognize WHO-listed Covaxin for travels to GER, starting June 1! This Embassy has been pushing very actively for such decision (because of Covid-backlogs visa sections have longer waiting periods than normal, please have patience),” tweeted, the German Ambassador to India and Bhutan Walter J Lindner.